Leading Research Director Joins Board of Trustees at Duchenne UK

Duchenne UK is pleased to announce the appointment of a new Trustee, Maria Hassard.Read more

Duchenne UK announces a new grant to Oxford University to investigate improved delivery of exon skipping drugs

Duchenne UK is pleased to announce its support of the development of the next generation of exon skipping drugsRead more

Duchenne UK hosts an industry workshop on Economic Modelling for HTA

The aim of the day was to work with companies developing potential treatments for DMD to best deal with the NICE processRead more

Fiona Lawrence is interviewed by Partnerships in Clinical Trials

Our Director of Research and Clinical Development discusses the challenges and innovations impacting rare disease research todayRead more

Duchenne UK participates in the recent NICE/ NHS England consultation

An update on Duchenne UK's participation in the recent NICE and NHS England consultationRead more

Duchenne Charities launch campaign for treatments for Adults with DMD

The joint campaign will ensure that treatments and therapies developed are relevant and available to adultsRead more

Eli Lilly and Company Joins cTAP

Helping to Accelerate Enriched Clinical Trial Design for the Provision of New Treatments for DMD PatientsRead more

Nutraceuticals and DMD

New review from researchers in Australia on the potential benefits of supplements. DUK is actively investing in this areaRead more

Duchess of Cornwall Honey

Proceeds from the sale of the Duchess of Cornwall's honey at Fortnum & Mason this Christmas, will be donated to Duchenne UKRead more

Partnerships in Clinical Trials Europe conference in Vienna

Fiona, Our Director of research and clinical development, attended Partnerships in Clinical Trials conferenceRead more